MENU
ERNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Eterna Therapeutics (ERNA) Ownership - Who owns Eterna Therapeutics?
Industry: @Medical Specialties
Profile
Industry
Medical Specialties
Address
1035 Cambridge Street
Phone
+1 212 582-1199
Employees
8
Web
https://www.eternatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.84M
P/E Ratio
N/A
Total Cash
4.26M
Projected Growth
N/A
Total Debt
33.55M
Revenue
598K
Risk (Beta)
1.86
Dividend Yield
N/A
Total Cash/Share
0.08
Total Debt/Equity
N/A
Revenue/Share
0.11 USD as % of share price
Fundamentals
ERNA
Capitalization
12.8M
P/E Ratio
N/A
Risk (Beta)
1.86
Dividend Yield
N/A
Total Cash
4.26M
Total Cash/Share
0.08
Total Debt
33.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.11%
Revenue
598K
ROE
N/A
Book Value
-45.39M
P/B Ratio
4.85
Cash Flow
N/A
Earnings
-8.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
27K
Current Ratio
0.48
Current Revenue Per Employee
60875.00
Dividends Per Share - Security
N/A
EBITDA
-39.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
112.32
Revenue To Assets
-149.92
Shares Held By Institutions
795K
Shares Outstanding - Current
51.4M
Total Liabilities
53.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-86.067
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biomedical research products in the field of stem cells and regenerative medicine
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1035 Cambridge Street
Phone
+1 212 582-1199
Employees
8
Web
https://www.eternatx.com